Anatomy
3 questionsWhich of the following statements is true regarding the anatomy of the external nose?
Which of the following arteries does NOT contribute to Little's area?
Posterior epistaxis occurs from:
NEET-PG 2013 - Anatomy NEET-PG Practice Questions and MCQs
Question 971: Which of the following statements is true regarding the anatomy of the external nose?
- A. The lower one-third is primarily cartilaginous. (Correct Answer)
- B. The upper two-thirds is entirely bony.
- C. The lateral aspect has only a single cartilage.
- D. The external nose is supported by two nasal bones.
Explanation: ***The lower one-third is primarily cartilaginous.*** - The **lower one-third** of the external nose, including the nasal tip and alae, is predominantly supported by **alar cartilages** (lower lateral cartilages) and other minor cartilages, giving it flexibility. - This cartilaginous structure allows for movement and shaping of the nostrils. - This statement is **anatomically accurate and complete**. *The upper two-thirds is entirely bony.* - This is **incorrect**. - The **upper one-third** is bony (nasal bones and frontal process of maxilla). - The **middle one-third** is primarily **cartilaginous** (upper lateral cartilages). - Therefore, the upper two-thirds consists of **both bone and cartilage**, not entirely bone. *The lateral aspect has only a single cartilage.* - This is **incorrect**. - The lateral aspect contains **multiple cartilages**: upper lateral cartilages, lower lateral (alar) cartilages, and accessory cartilages. - The presence of multiple cartilages provides structural support and flexibility. *The external nose is supported by two nasal bones.* - This is **incomplete and misleading**. - While two **nasal bones** do form the superior bony bridge (upper one-third), the external nose is also supported by: - Frontal process of the maxilla - Upper and lower lateral cartilages - Septal cartilage - Stating only the nasal bones ignores the majority of nasal support structures.
Question 972: Which of the following arteries does NOT contribute to Little's area?
- A. Sphenopalatine artery
- B. Posterior Ethmoidal artery (Correct Answer)
- C. Greater palatine artery
- D. Anterior Ethmoidal artery
Explanation: Posterior Ethmoidal artery - The posterior ethmoidal artery primarily supplies the posterior ethmoidal cells and part of the sphenoid sinus, but it does not contribute to the vascular plexus in Little's area. - Little's area, also known as Kiesselbach's plexus, is formed by anastomoses of several arteries on the anterior nasal septum. Sphenopalatine artery - The sphenopalatine artery, a terminal branch of the maxillary artery, is a major contributor to Little's area through its septal branch. - It supplies a significant portion of the nasal septum and is frequently involved in posterior epistaxis. Greater palatine artery - The greater palatine artery, a branch of the descending palatine artery (from the maxillary artery), enters the nasal cavity through the incisive canal and contributes to Little's area on the nasal septum. - It primarily supplies the hard palate and then anastomoses with other vessels in the anterior nasal septum. Anterior Ethmoidal artery - The anterior ethmoidal artery, a branch of the ophthalmic artery, is a key contributor to Little's area. - It supplies the anterior and middle ethmoidal cells and also contributes to the blood supply of the dura mater.
Question 973: Posterior epistaxis occurs from:
- A. Kiesselbach's plexus
- B. Sphenopalatine artery
- C. Little's area
- D. Woodruff's plexus (Correct Answer)
Explanation: ***Woodruff's plexus*** - **Woodruff's plexus** is a collection of large, often friable veins located on the **posterior aspect of the lateral wall of the nasal cavity**, making it the most common anatomical site for **posterior epistaxis**. - Bleeding from this plexus is typically more severe and difficult to control than anterior epistaxis due to the larger vessel size and posterior location. - Located in the **posterolateral nasal cavity** near the posterior end of the inferior turbinate. *Kiesselbach's plexus* - **Kiesselbach's plexus** (also known as Little's area) is located on the **anterior nasal septum** and is the most common site for **anterior epistaxis**. - This is an anastomotic network of vessels from multiple arterial sources in the anterior nasal cavity. - Bleeding from this plexus is usually less severe and often responds to local pressure or cauterization. *Sphenopalatine artery* - The **sphenopalatine artery** is the terminal branch of the maxillary artery and is the primary arterial supply to the posterior nasal cavity. - While it supplies the area where posterior epistaxis occurs, the venous **Woodruff's plexus** is the specific anatomical structure most commonly associated with posterior epistaxis. - The sphenopalatine artery may require ligation or embolization in severe posterior epistaxis cases. *Little's area* - **Little's area** is another name for **Kiesselbach's plexus** and is located on the **anterior nasal septum**, primarily responsible for anterior epistaxis. - This area is highly vascularized by anastomoses of the anterior ethmoidal, sphenopalatine, greater palatine, superior labial, and septal branches of arteries. - Prone to bleeding from minor trauma, digital manipulation, or mucosal dryness.
Dermatology
2 questionsWhich of the following statements is true about rhinophyma?
What is the condition characterized by the hypertrophy of sebaceous glands?
NEET-PG 2013 - Dermatology NEET-PG Practice Questions and MCQs
Question 971: Which of the following statements is true about rhinophyma?
- A. Premalignant
- B. Common in alcoholics
- C. Acne rosacea (Correct Answer)
- D. Fungal etiology
Explanation: ***Acne rosacea*** - **Rhinophyma** is a severe form of **acne rosacea**, characterized by sebaceous gland hypertrophy and connective tissue hyperplasia on the nose. - It specifically represents the **phymatous subtype** of rosacea, which involves thickening of the skin. *Premalignant* - Rhinophyma itself is generally **not considered premalignant** to skin cancer. - While skin cancers like **basal cell carcinoma** can rarely occur within rhinophyma, the condition itself does not inherently transform into malignancy. *Common in alcoholics* - This is a **common misconception**; while often associated with heavy alcohol use, there is no direct causal link. - The development of rhinophyma is primarily driven by the underlying pathogenesis of **rosacea**, not alcohol consumption. *Fungal etiology* - Rhinophyma is primarily an inflammatory skin condition, not caused by **fungal infection**. - Its etiology is complex, involving genetics, environmental triggers, and vascular dysregulation, but **microbial involvement** is typically bacterial (e.g., Demodex mites) rather than fungal.
Question 972: What is the condition characterized by the hypertrophy of sebaceous glands?
- A. Rhinosporidiosis
- B. Tubercular infection
- C. Sebaceous hyperplasia (Correct Answer)
- D. Nasopharyngeal angiofibroma
Explanation: ***Sebaceous hyperplasia*** - This condition is characterized by the **enlargement (hypertrophy)** of normal sebaceous glands, often appearing as yellowish-white papules with a central umbilication. - It commonly occurs on the **face of older adults**, particularly on the forehead and cheeks, and is a benign condition. *Rhinosporidiosis* - This is a **chronic granulomatous disease** caused by the fungus *Rhinosporidium seeberi*, primarily affecting the **mucous membranes** of the nose and nasopharynx. - It presents as **friable, polypoidal masses** with a characteristic "strawberry-like" appearance due to small white spots (sporangia), not sebaceous gland hypertrophy. *Tubercular infection* - A tubercular infection, particularly cutaneous tuberculosis, can manifest in various forms, including **lupus vulgaris**, scrofuloderma, or tuberculosis cutis verrucosa. - These presentations involve **granulomatous inflammation** and tissue destruction, not isolated hypertrophy of sebaceous glands. *Nasopharyngeal angiofibroma* - This is a **rare, benign, highly vascular tumor** that originates in the nasopharynx, predominantly affecting adolescent males. - It typically presents with symptoms like **epistaxis** and **nasal obstruction**, and is composed of fibrous and vascular tissue, not sebaceous glands.
ENT
4 questionsWhat is not true about the use of intranasal steroids in nasal polyposis?
Which of the following statements about Rhinoscleroma is false?
Which of the following is a predisposing factor for nasal myiasis?
In which condition is mulberry nasal mucosa typically observed?
NEET-PG 2013 - ENT NEET-PG Practice Questions and MCQs
Question 971: What is not true about the use of intranasal steroids in nasal polyposis?
- A. Effective in all types of nasal polyps (Correct Answer)
- B. May cause nasal irritation
- C. Reduce recurrence
- D. Most effective in eosinophilically predominant polyps
Explanation: ***Effective in all types of nasal polyps*** - Intranasal steroids are primarily effective in nasal polyps with an **eosinophilic inflammatory component**, which is the most common type. - They are **not effective in all types** - efficacy is significantly reduced in polyps with **neutrophilic inflammation** or those related to conditions like **cystic fibrosis**, reflecting different underlying pathologies. - This statement is **FALSE**, making it the correct answer to this negation question. *May cause nasal irritation* - **Nasal irritation**, including **burning, stinging**, or **dryness**, is a common local side effect associated with the use of intranasal steroids. - Other local side effects can include **epistaxis** (nosebleeds) and mucosal atrophy, though less common. - This statement is **TRUE**. *Reduce recurrence* - **Intranasal steroids** are crucial in **reducing the recurrence** of nasal polyps after surgical removal. - Their anti-inflammatory action helps to **control the underlying inflammation** that contributes to polyp formation. - This statement is **TRUE**. *Most effective in eosinophilically predominant polyps* - Intranasal steroids primarily target the **eosinophilic inflammatory pathway**, which is characteristic of the majority of **chronic rhinosinusitis with nasal polyps (CRSwNP)**. - While they have **maximal efficacy** in eosinophilic polyps, they may have limited benefit in mixed inflammatory patterns. - Their efficacy is significantly reduced in polyps that are predominantly **neutrophilic** or associated with systemic conditions like **cystic fibrosis**, as these involve different inflammatory mechanisms. - This statement is **TRUE**.
Question 972: Which of the following statements about Rhinoscleroma is false?
- A. Woody nose
- B. Mikulicz cells
- C. More common in tropical regions (Correct Answer)
- D. Caused by bacteria
Explanation: ***More common in tropical regions*** - While rhinoscleroma is endemic in certain regions, it is more commonly found in **temperate and subtropical climates**, particularly in Eastern Europe, Central and South America, and parts of Africa and Asia, rather than exclusively tropical areas. - The prevalence is linked to socioeconomic factors and poor hygiene rather than strictly temperature-based climate zones. *Mikulicz cells* - The presence of **Mikulicz cells** is a characteristic histopathological feature of rhinoscleroma. - These are large macrophages with a clear, foamy cytoplasm containing numerous bacilli, which are pathognomonic for the disease. *Woody nose* - **Woody nose** (or "saddle nose" deformity in late stages) is a clinical feature associated with the advanced stages of rhinoscleroma. - The disease causes chronic inflammation and granuloma formation, leading to firm, indurated infiltrates that can result in this characteristic nasal deformity. *Caused by bacteria* - Rhinoscleroma is indeed caused by the bacterium **_Klebsiella rhinoscleromatis_**, a gram-negative rod. - It is an infectious disease primarily affecting the upper respiratory tract.
Question 973: Which of the following is a predisposing factor for nasal myiasis?
- A. Allergic rhinitis
- B. Vasomotor rhinitis
- C. Atrophic rhinitis (Correct Answer)
- D. Rhinitis medicamentosa
Explanation: ***Atrophic rhinitis*** - **Atrophic rhinitis** leads to thinning and drying of the nasal mucosa, creating a favorable environment for **fly larvae (maggots)** to infest. - The **crusting and foul odor** associated with atrophic rhinitis can attract flies, making the nasal cavity susceptible to myiasis. *Allergic rhinitis* - Characterized by **inflammation and watery discharge** due to allergen exposure. It does not create the tissue damage or conducive environment for myiasis. - While it causes nasal symptoms, it generally **does not involve tissue necrosis** or open lesions that would attract flies for oviposition. *Vasomotor rhinitis* - Involves **non-allergic triggers** causing nasal congestion, sneezing, and runny nose, often due to autonomic nervous system dysfunction. - There is **no tissue destruction or mucosal atrophy** that would predispose to myiasis. *Rhinitis medicamentosa* - Results from **overuse of topical decongestant sprays**, leading to rebound congestion and chronic inflammation. - While it causes nasal irritation, it does **not typically involve the extensive mucosal damage or open wounds** that attract flies for myiasis.
Question 974: In which condition is mulberry nasal mucosa typically observed?
- A. Lupus vulgaris (Correct Answer)
- B. Vasomotor rhinitis
- C. Atrophic rhinitis
- D. Allergic rhinitis
Explanation: ***Lupus vulgaris*** - **Mulberry nasal mucosa** is a **pathognomonic finding** in **lupus vulgaris**, a form of cutaneous tuberculosis affecting the nasal mucosa. - The mucosa shows characteristic **reddish-brown, soft nodules** that resemble mulberries, with a typical **apple-jelly appearance on diascopy**. - Lesions are **persistent, slowly progressive**, and may cause destruction of the nasal cartilage if untreated. *Vasomotor rhinitis* - **Vasomotor rhinitis** (non-allergic rhinitis) presents with **pale, bluish, or boggy nasal mucosa**, not the mulberry appearance. - Caused by **autonomic nervous system dysregulation**, leading to nasal congestion and rhinorrhea triggered by non-allergic stimuli. - The mucosal changes are **diffusely edematous** rather than nodular. *Atrophic rhinitis* - **Atrophic rhinitis** involves progressive atrophy of the nasal mucosa and underlying bone. - Mucosa appears **pale, dry, smooth, and shiny** with thick crusts (ozena in secondary form). - Wide nasal cavities with paradoxical nasal obstruction, **not mulberry-like nodular changes**. *Allergic rhinitis* - **Allergic rhinitis** typically shows **pale, edematous, bluish-gray mucosa** with watery discharge. - Caused by **IgE-mediated hypersensitivity** to environmental allergens. - Mucosa may appear **boggy but not nodular or mulberry-like**.
Internal Medicine
1 questionsAll are seen in Samters triad except?
NEET-PG 2013 - Internal Medicine NEET-PG Practice Questions and MCQs
Question 971: All are seen in Samters triad except?
- A. Nasal polyp
- B. Aspirin sensitivity
- C. Asthma
- D. Bacterial infection (Correct Answer)
Explanation: ***Bacterial infection*** - **Samter's triad**, also known as aspirin-exacerbated respiratory disease (AERD), consists of **asthma**, **nasal polyps**, and **aspirin sensitivity** (or NSAID sensitivity) [1]. - **Bacterial infection** is not a component of Samter's triad, although patients with nasal polyps may be more prone to secondary bacterial sinusitis. *Asthma* - **Asthma** is one of the three main components of Samter's triad, typically becoming more symptomatic after aspirin ingestion [1]. - Patients experience **bronchoconstriction** and worsening respiratory symptoms. *Nasal polyp* - **Nasal polyps** are a characteristic feature of Samter's triad, often extensive and recurrent [1]. - They contribute to nasal obstruction and chronic rhinosinusitis. *Aspirin sensitivity* - **Aspirin sensitivity** (or NSAID sensitivity) is the third key component, where ingestion of aspirin or other NSAIDs triggers severe respiratory reactions [1]. - This sensitivity is due to an abnormal arachidonic acid metabolism pathway involving **leukotrienes**.